“SmartHeart® 12 Lead ECG technology has further enabled our company to achieve our goals of improved access to our board-certified cardiovascular specialists within seconds.”
“SmartHeart® 12 Lead ECG technology has further enabled our company to achieve our goals of improved access to our board-certified cardiovascular specialists within seconds.”
The cost of care for patients with acute myocardial infarction continues after patients leave the hospital. At-home solutions offer a cost-effective means to manage cardiovascular disease. Telehealth services facilitated by SmartHeart®, the only FDA-cleared, hospital-grade, remote 12-lead ECG, enables substantial cost savings, while improving outcomes and patient satisfaction.
